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Abstract
Hepatoma-derived growth factor (HDGF) related protein 2 (HRP2) and lens epithelium-
derived growth factor (LEDGF)/p75 are closely related members of the HRP2 protein family.
LEDGF/p75 has been implicated in numerous human pathologies including cancer, autoim-
munity, and infectious disease. Knockout of the Psip1 gene, which encodes for LEDGF/p75
and the shorter LEDGF/p52 isoform, was previously shown to cause perinatal lethality in
mice. The function of HRP2 was by contrast largely unknown. To learn about the role of
HRP2 in development, we knocked out the Hdgfrp2 gene, which encodes for HRP2, in both
normal and Psip1 knockout mice. Hdgfrp2 knockout mice developed normally and were
fertile. By contrast, the double deficient mice died at approximate embryonic day (E) 13.5.
Histological examination revealed ventricular septal defect (VSD) associated with E14.5
double knockout embryos. To investigate the underlying molecular mechanism(s), RNA
recovered from ventricular tissue was subjected to RNA-sequencing on the Illumina plat-
form. Bioinformatic analysis revealed several genes and biological pathways that were sig-
nificantly deregulated by the Psip1 knockout and/or Psip1/Hdgfrp2 double knockout.
Among the dozen genes known to encode for LEDGF/p75 binding factors, only the expres-
sion of Nova1, which encodes an RNA splicing factor, was significantly deregulated by the
knockouts. However the expression of other RNA splicing factors, including the LEDGF/
p52-interacting protein ASF/SF2, was not significantly altered, indicating that deregulation
of global RNA splicing was not a driving factor in the pathology of the VSD. Tumor growth
factor (Tgf) β-signaling, which plays a key role in cardiac morphogenesis during develop-
ment, was the only pathway significantly deregulated by the double knockout as compared
to control and Psip1 knockout samples. We accordingly speculate that deregulated Tgf-β
signaling was a contributing factor to the VSD and prenatal lethality of Psip1/Hdgfrp2 dou-
ble-deficient mice.
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Introduction
Members of the hepatoma-derived growth factor (HDGF) related protein (HRP) family have
been implicated in numerous human diseases including cancer, autoimmunity, and virus infec-
tion [1, 2]. The family consists of six members including HDGF, HRP1, HRP2, HRP3, and lens
epithelium-derived growth factor (LEDGF)/p52 and LEDGF/p75, the latter two of which are
expressed from the PC4 and SFRS1-interacting protein 1 (Psip1) gene as splice variants [3].
The most common feature among these proteins is an N-terminally situated PWWP (Pro-Trp-
Trp-Pro) domain [4], which is a type of Tudor domain [5]. Two of the proteins, LEDGF/p75
and HRP2, contain a second evolutionarily conserved domain, which we previously termed the
integrase-binding domain because it was both necessary and sufficient to convey binding to
lentiviral integrase proteins [3, 6, 7]. LEDGF/p75, which is an important lentiviral integrase
cofactor, helps to guide the integration of the viral reverse transcripts into the bodies of active
genes (see [1] and [8] for review).
Despite possessing a functional integrase-binding domain [3], HRP2 unlike LEDGF/p75
does not appear under normal circumstances to play a role in lentiviral DNA integration. A
subsidiary role for HRP2 in guiding human immunodeficiency virus type 1 (HIV-1) integra-
tion to active genes was however uncovered by either knocking down [9] or knocking out [10]
the expression of HRP2 in Psip1 knockout cells that are completely devoid of LEDGF/p75
expression. Two differences between HRP2 and LEDGF/p75 are likely to contribute to the
inability for HRP2 to contribute to viral DNA integration under normal circumstances. Firstly,
whereas LEDGF/p75 associates with chromatin throughout the cell cycle [11–13], HRP2,
though localized to the cell nucleus, does not associate with chromatin [13, 14]. Secondly, the
affinity of the HRP2-integrase interaction is lower than the affinity of the LEDGF/p75-inte-
grase interaction [3, 13].
We previously knocked out Psip1 [15] and Hdgfrp2 (the gene that encodes for HRP2) [10]
in mice to generate mouse embryo fibroblasts (MEFs) as cell models for HIV-1 infection. In
this report we detail the phenotypes of the knockout animals. Bickmore and colleagues previ-
ously described that the majority of Psip1 knockout mice generated via gene trap vector inser-
tion died perinatally [16], a result recapitulated here through Cre/lox-mediated disruption of
the Psip1 gene. We additionally found that Psip1/Hdgfrp2 double deficient mice displayed a
high rate of prenatal mortality, with the underlying pathology of ventricular septal defect
(VSD) mapping to approximate embryonic day (E) 13.5. Illumina-based sequencing of RNA
transcripts (RNA-Seq) derived from tissues of Psip1 knockout, Psip1/Hdgfrp2 double knock-
out, and littermate-matched control animals revealed genes and pathways that were deregu-
lated by the double knockout including tumor growth factor (Tgf)-β signaling, extracellular
matrix (Ecm)-receptor interaction, and focal adhesion. Deregulation of these pathways may
contribute to the VSD and the mortality of the mice.
Material and Methods
Knockout animals and MEF cells
The procedures used to generate Psip1,Hdgfrp2, and Psip1/Hdgfrp2 knockout mice were
described previously [10, 15]. In brief, LEDGF/p75 expression was knocked out by deleting
exon 3 of the Psip1 gene, which is the second coding exon, using Cre/lox-mediated DNA
recombination [15]. Embryonic stem (ES) cells that harbored the insertion of the pGT2lfx gene
trap vector between exons 3 and 4 ofHdgfrp2 were obtained from BayGenomics [10]. Chimeric
animals obtained from implanting ES cells that were disrupted for either the Psip1 or Hdgfrp2
gene were backcrossed to C57BL/6 mice (Charles River Laboratories) to yield heterozygous
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Psip1 (+/-) and Hdgfrp2 (+/g) animals. The heterozygous mice were mated to yield Psip1 (-/-)
knockout, Hdgfrp2 (g/g) knockout, or heterozygous +-/g+ and +-/gg animals, the latter of
which were further interbred to yield −−/gg double knockout animals [10]. The statistical rele-
vance of observed frequencies of mouse genotypes was assessed versus the expected Mendelian
frequencies using the chi-square test.
The E9 and E13 sets of WT (++/+g), Psip1 knockout (−−/+g), and Psip1/Hdgfrp2 double
knockout (−−/gg) MEF cell lines were previously described [10].
PCR analysis of mouse genomic DNA
Genotyping was performed by Southern blotting and by PCR [10, 15]. In brief, DNA prepared
from mouse tissue using the QIAamp DNAmicro kit (Qiagen) was PCR-amplified using prim-
ers AE2331 and AE2802 to monitor the status of the Psip1 gene [15] and primer pairs AE2511/
AE2512 and AE3747/AE3748 to monitor theHdgfrp2 locus [10]. S1 Table lists the sequences
of the PCR primers that were used in this study.
The sex-determining region Y (Sry) gene was amplified using primers AE6796/AE6797 and
50 ng genomic DNA under cycling conditions: 98°C for 5 min, followed by 30 cycles of 30 sec
at 98°C, 30 sec at 56°C, 15 sec at 72°C, followed by a final 10-min extension at 72°C. The result-
ing 273 bp Sry-specific amplification product was visualized by staining with ethidium bromide
following agarose gel electrophoresis.
Quantitative (q) RT-PCR
The concentration of RNA extracted from mouse tissue using the RNeasy Mini Kit (Qiagen)
was determined by spectrophotometry. Duplicate qRT-PCR mixtures contained 0.5 μM prim-
ers, 1×Quantitect SYBR green master mix, 0.3 μl QuantiTect RT mix (QuantiTect Sybr Green
RT-PCR kit), and 25 ng of RNA. Psip1 expression was monitored using primers AE2624/
AE2625, which anneal to exons 2 and 3 [15]. Primers AE3160/AE3161 were used to amplify
Hdgfrp2 exons 1/2 whereas downstream exon 5/7 sequences were amplified using primers
AE2553/2554 [10]. Gene expression data were normalized to Ppia, which encodes for cyclophi-
lin A, using primers AE3664/AE3665 [10]. PCR cycling conditions were as described [10]. Sig-
nificance between levels of gene expression was assessed by one-tailed t test.
RNA-Seq analysis
Embryo hearts were dissected from euthanized E14.5 animals, and the ventricular tissue was
isolated from the atrial chambers. RNA extracted from the ventricles using the RNeasy kit was
subjected to the RNA-Seq pipeline at the Center for Cancer Computational Biology (Dana-Far-
ber Cancer Institute). RNA was analyzed for quality control using Qubit fluorometric quantita-
tion (Life Technologies) and Bioanalyzer (Agilent Technologies). RNA (50–100 ng) was
converted into DNA libraries using the NEBNext Ultra RNA Library Prep Kit for Illumina
(New England Biolabs). The quality of the DNA libraries was assessed using the Qubit High
Sensitivity DNA Kit (Life Technologies) and library size was determined using the Bioanalyzer
High Sensitivity Chip Kit (Agilent Technologies). Libraries that passed quality control were
diluted to 2 nM using sterile water and then sequenced on the MiSeq2000 platform (Illumina)
at the concentration of 12 pM on a single read flowcell with 50 sequencing cycles.
Western blotting
Mouse tissue was lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mMNaCl, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1 mM EDTA) containing 1x
Embryonic Lethality from Psip1/Hdgfrp2 Double Knockout
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protease inhibitor cocktail (Roche Diagnostics). The samples were subjected to sonication for
5 to 10 sec, followed by centrifugation at 16,000 g for 5 min at 4°C. The concentration of super-
natant protein was determined using the Bio-Rad DC Protein Assay Kit, and 5 μg was fraction-
ated through 8% polyacrylamide gels under denaturing conditions. Proteins transferred to poly
(vinylidene difluoride) membrane were probed with anti-Smad2/3 antibodies (Cell Signaling)
at 1:1,000 dilution. Primary antibody binding was visualized using horseradish peroxidase-con-
jugated rabbit anti-mouse antibodies (Dako Scientific) and enhanced chemiluminescence
(Thermo Scientific). Membranes were reprobed with horseradish peroxidase-conjugated anti-
body against β-actin (1:10,000 dilution, Cell Signaling) to control for the amount of protein
loaded onto the gels. Membranes were imaged on a ChemiDoc MP imager (Bio-Rad) and sig-
nals were quantified using Image Lab 4.1 software.
Bioinformatics and statistical analyses
Sequence reads were mapped toMus musculus reference genome mm9 (build name NCBIM
37) using TopHat [17]. HTSeq was used to map the reads to each gene from the alignment
BAM file [18]. EdgeR was used to analyze differential gene expression [19]. Read counts from
triplicate RNA samples were first normalized to library size, then relatively low expressed
genes were filtered out by using the threshold setting of one read per kb per million reads
(RPKM). Testing for differentially expressed genes was based on a negative binomial model.
Significant differential expression was filtered using a false discovery rate of< 0.05. The top
20 differentially expressed genes were additionally sorted by P value.
To analyze gene ontology, the differentially expressed genes identified using EdgeR were
processed by the online tool provided by www.biomart.com. Gene set and pathway analysis
was performed using the Generally Applicable Gene-set Enrichment (GAGE) [20] package and
the results were presented in KEGG pathway [21, 22]. Significantly regulated pathways were fil-
tered using a q value of< 0.1. Pathview [23] was utilized to visualize results as indicated.
Histological analysis of mouse tissue
Mouse tissue was fixed in Bouin’s fixative (Sigma-Aldrich). Tissues were embedded in paraffin,
sectioned at 6 μm, stained with hematoxylin/eosin, and analyzed by light microscopy at the
Rodent Histopathology Core at Harvard Medical School.
Ethics statement
This study was carried out under strict supervision of the Beth Israel Deaconess Medical Center
(BIDMC) Institutional Animal Care and Use Committee (IACUC) under guidelines set forth
by the United States Department of Agriculture (USDA) and US Public Health Service (PHS)
Office of Lab Animal Welfare (OLAW). The BIDMC IACUC, which is accredited by the Asso-
ciation for Assessment and Accreditation of Laboratory Animal Care (approval date March 25,
2014) and US PHS Assurance code A3153-01 (expiration date February 28, 2018), approved
this study as part of animal protocol number 038–2012 (“Breeding LEDGF and HRP2 knock-
out mice”).
Mice were identified using ear punches and the universal mouse numbering system in
accordance with Institutional and Federal guidelines. Tips (2–4 mm) of mice tails were snipped
for genotyping purposes using an extremely sharp blade (scalpel or razor blade), and hemosta-
sis was performed before returning the animals to cages to minimize any associated discomfort.
Pregnant mothers were euthanized by CO2 inhalation for 10 min using a smart box chamber
system (Euthanex).
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Results and Discussion
Generation of knockout mice
Several strains of mutant mice were generated to investigate the roles of Psip1 andHdgfrp2 in
mouse development. Psip1 was knocked out using Cre/lox DNA recombination [15] and
Hdgfrp2 was disrupted by gene trap insertion [10]. Heterozygous animals (+/- for Psip1; +/g
for Hdgfrp2) were then interbred to generate Psip1/Hdgfrp2 double knockout animals. Because
Hdgfrp2 (g/g) knockout animals reached adulthood (see below) and were fertile, +-/+g hetero-
zygous animals were mated to +-/gg Hdgfrp2 knockout animals to increase the theoretical
frequency of double knockout production from 6.25% to 12.5% of offspring. All animals gener-
ated from the double knockout mating scheme were therefore either Hdgfrp2 (+/g) or Hdgfrp2
(g/g).
The genotypes of knockout animals were monitored using PCR and Southern blotting
whereas gene expression profiles were monitored by qRT-PCR and western blotting [10, 15].
Examples of these measurements for animals generated by the double knockout mating scheme
are presented in S1A–S1C Fig. Two sets of qRT-PCR primers were used to monitor Hdgfrp2
expression: exon 1/2-specific primers detected sequences upstream from the gene trap inser-
tion, whereas exon 5/7 primers monitored expression downstream from the insertion. The
gene trap vector reduced the expression level of exon 1/2-containing sequences approximately
5 fold relative to a ++/+g littermate-matched control animal, whereas exon 5/7-contaning
sequences were further reduced, to about 15-to-25 fold, compared to the control. The level of
Hdgfrp2 expression was by contrast unaffected by Psip1 knockout in the +/g background (S1B
Fig). Psip1 knockout reduced the level of LEDGF/p75 mRNA between 300 and 1000 fold,
whereas Psip1 heterozygosity (+/-) yielded an approximate 2-fold reduction in message (S1C
Fig). The strength of gene trap knockout depends on the position of vector integration in the
mouse genome [24, 25] and we accordingly expect that this parameter impacted the magnitude
of the Hdgfrp2mRNA reduction as compared to the more potent reduction in Psip1message
that was achieved through Cre/lox-mediated DNA deletion (S1 Fig) [10]. Western blot analysis
confirmed the lack of detectable HRP2 and LEDGF/p75 protein expression in MEF cells iso-
lated from Psip1/Hdgfrp2 double-deficient animals [10].
Phenotypic characterization of knockout animals
To ascertain the affect of gene knockout on mouse development, offspring of timed heterozy-
gous animal matings were genotyped at various time points before and/or after birth. The
monitoring of 125 animals at weaning age (21 days post-birth) revealed no affect from the
Hdgfrp2 knockout on development, as the frequency of the three expected genotypes (+/+, +/g,
and g/g) were indistinguishable from the predicted Mendelian frequencies of 1:2:1 (Table 1,
P = 0.96). Hdgfrp2 knockout mice appeared physically normal and were fertile. The 16-exon
Hdgfrp2 gene yields three mRNA isoforms that differ in the extent of exon 3 and 4 or exon 7
content [26]. The expression of all three isoforms is predictably disrupted by the utilized gene
trap vector, which was inserted within the large intron between exons 3 and 4 [10, 26]. We
note that mice knocked out for the namesake member of the HRP gene family, Hdgf, were like-
wise phenotypically normal [27].
Psip1 knockout through gene trap vector insertion was previously reported to severely
impact mouse development, as most of the mice died perinatally [16]. Embryos resulting from
Psip1 (+/-) crosses were accordingly genotyped at numerous time points including E13.5,
E15.5, and E17.5. Because knockout-/- animals were recovered at or above the predictive Men-
delian frequency of 25% at all three times, we conclude that the null Psip1 allele generated via
Embryonic Lethality from Psip1/Hdgfrp2 Double Knockout
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DNA deletion was not grossly deleterious to mouse embryogenesis. By contrast, only four of
302 animals reached the weaning age of 21 days (Table 2), a phenotype that is fully consistent
with the perinatal lethality observed with gene trap knockout animals [16]. Histological charac-
terization of surviving knockout mice revealed minor skeletal alterations consistent with those
reported by Bickmore and colleagues (data not shown) [16]. Additional detailed histopathol-
ogy of our Psip1 knockout animals was accordingly not performed. Due to deletion of proximal
exon 3 from the Psip1 gene, we note that our genetically null animals, similar to those gener-
ated by the previously described gene trap insertion, were defective for expressing both LEDGF
(p52 and p75) isoforms [15, 16].
Due to the perinatal lethality associated with Psip1 knockout, we expected few if any Psip1/
Hdgfrp2 double knockout animals to survive to 21 days of age. Indeed, out of 322 animals, only
two were genotyped as double knockout (Table 3). To ascertain when double knockout animals
succumbed during development, embryos were genotyped at several time points. The percent-
age of double knockout animals recovered at E9.5, E11.5 and E12.5 did not significantly differ
from the predicted Mendelian frequency of 12.5% (Table 3). By contrast, far fewer animals
than predicted were recovered at E13.5, E14.5, and E15.5. Therefore, unlike the consequence
from the sole knockout of Psip1 [16] (Table 2), Psip1/Hdgfrp2 double knockout animals suc-
cumbed during embryogenesis, at approximately E13.5.
Two Psip1/Hdgfrp2 double knockout mice notably survived to adulthood (Table 3). Both
animals had obvious retarded movement (not shown) and the tendency to clench their hind
limbs to their bodies (Fig 1A), phenotypes similar to those previously reported for Psip1 knock-
out animals [16]. To test if these animals harbored Psip1 and/or Hdgfrp2 expression profiles
that differed from those expected from dual knockout deficiency (S1 Fig), mRNA prepared
from blood was compared to samples isolated from littermate matched +-/+g animals by
qRT-PCR. As expected from the stable nature of DNA deletion, the Psip1 gene expression pro-
files of these double knockout animals were decreased in comparison to the controls (Fig 1B).
As previously noted, the expression of Hdgfrp2 sequences downstream from the gene trap
insertion in heterozygous (+-/+g) control animals, which was detected using exon 5/7-specific
primers, was reduced by approximately twofold as compared to mRNA isolated from a
Hdgfrp2 +/+ control [10] (Fig 1C). The Hdgfrp2 expression patterns of the double deficient
Table 1. Genotypes of offspring from timedmatings of Hdgfrp2 heterozygous (+/g) animals.
Number (%) of embryos
Time point +/+ +/g g/g Total P value
Weaning age 30 (24.0) 64 (51.2) 31 (24.8) 125 0.96
Expected values 31 (24.8) 63 (50.4) 31 (24.8) 125
doi:10.1371/journal.pone.0137797.t001
Table 2. Genotypes of offspring from timedmatings of Psip1 heterozygous (+/-) animals.
Number (%) of embryos
Time point +/+ +/- -/- Total P value
E13.5 2 (8.0) 10 (40.0) 13 (52.0) 25 <0.0001
E15.5 6 (35.3) 8 (47.1) 3 (17.6) 17 0.51
E17.5 3 (27.3) 4 (36.4) 4 (36.4) 11 0.61
Weaning age 113 (37.4) 185 (61.3) 4 (1.3) 302 <0.0001
Expected values 25% 50% 25%
doi:10.1371/journal.pone.0137797.t002
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animals differed greatly from those expected from the g/g knockout (compare Fig 1C with S1B
Fig). The levels of exon 5/7-containing mRNA in the litter 1 −−/gg animal was not significantly
different from its +-/+g sibling, whereas in the litter 2 animal this level was reduced< 2-fold
from the matched sibling. Although this difference was statistically significant, the level of
Hdgfrp2message distal from the gene trap in both double knockout animals matched or
exceeded the level detected using upstream exon 1/2 primers (Fig 1C). We therefore suspect
that mRNA read-through of the gene trap vector contributed to the survival of these two ani-
mals. The results of PCR analysis revealed that each surviving animal retained the integrated
gene trap vector (not shown). Read through of the gene trap vector effectively converted the
phenotype of these two animals to that of surviving Psip1 knockout mice.
Abnormal cardiac morphogenesis in Psip1/Hdgfrp2 knockout mice
E14.5 embryos were histologically analyzed to investigate gross developmental defects associ-
ated with the double knockout. Serial sagittal dissection revealed subcutaneous edema and
hemorrhage compared to ++/+g control animals (Fig 2A). Generalized edema is often a sign of
failure in the circulatory system due to cardiac defects [28, 29]. Consistent with this, serial
transverse sections demonstrated the consistent presence of VSD in double knockout but not
in matched ++/+g control or Psip1 (−−/+g) knockout animals (Fig 2B). The structures of the
great aorta and pulmonary arteries by contrast appeared normal in the double knockout
embryos (data not shown). The structures of other organs, such as brain, lung, liver, kidney,
and intestines, also appeared normal in the double knockout animals (Fig 2A).
Transcriptional profiling of Psip1 and Psip1/Hdgfrp2 knockout mice
To probe the molecular mechanisms that underlie the mouse knockout phenotypes, RNA
extracted from heart ventricle tissue of E14.5 control ++/+g, Psip1 (−−/+g) knockout, and
double knockout embryos was subjected to RNA-Seq. The utilization of tissue from three
independent sets of littermate-matched dissections afforded data filtration for biological
reproducibility.
A total of 12,306 protein-coding genes was detected by RNA-Seq analysis. The parsing
of data in pairwise combinations revealed Psip1 as a driving force behind differential gene
expression. As shown in Table 4, 399 differentially expressed genes were determined by com-
paring the Psip1 knockout and ++/+g control samples (186 up-regulated and 213 down-regu-
lated genes), whereas 406 genes between the double knockout and control samples were
differentially expressed. Because comparing the knockout samples to each other yielded 37
Table 3. Genotypes of offspring from timedmatings of Psip1/Hdgfrp2 +-/+g and +-/gg animals.
Number (%) of embryos
Time Point ++/+g ++/gg +-/+g +-/gg −−/+g −−/gg n P value
E9.5 4 (6.9) 9 (15.5) 16 (27.6) 16 (27.6) 4 (6.9) 9 (15.5) 58 0.22
E11.5 8 (16.7) 8 (16.7) 8 (16.7) 11 (22.9) 5 (10.4) 8 (16.7) 48 0.19
E12.5 9 (16.1) 8 (14.3) 13 (23.2) 11 (19.6) 9 (16.1) 6 (10.7) 56 0.57
E13.5 33 (18.2) 18 (9.9) 72 (39.8) 24 (13.3) 26 (14.4) 8 (4.4) 181 0.02
E14.5 45 (19.1) 41 (17.4) 69 (29.4) 55 (23.4) 13 (5.5) 12 (5.1) 235 0.01
E15.5 10 (15.6) 8 (12.5) 22 (34.4) 19 (29.7) 3 (4.7) 2 (3.1) 64 0.04
Weaning 113 (35.1) 44 (13.7) 131 (40.7) 29 (9.0) 3 (0.9) 2 (0.6) 322 <0.0001
Expected 12.5% 12.5% 25.0% 25.0% 12.5% 12.5%
doi:10.1371/journal.pone.0137797.t003
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Fig 1. Phenotypic analysis of surviving Psip1/Hdgfrp2 knockout mice. (A) The −−/gg mouse on the left,
as compared to the littermate-matched heterozygous animal, revealed the tendency to clench its hind limbs.
(B) Analysis of Psip1 expression levels by qRT-PCR. (C) Levels ofHdgfrp2 expression upstream and
downstream from the gene trap insertion were detected by qRT-PCR using exon 1/2- and exon 5/7-specific
primers, respectively. Heterozygous +-/+g littermate control animals for the two knockout animals (litter 1 and
litter 2) and RNA from an unrelated Psip1 heterozygous (+-/++) animal [15] served as controls in panels B
and C. Panels B and C data are averages and standard deviation derived from three independent
experiments. n.s., not significant; *, P < 0.05.
doi:10.1371/journal.pone.0137797.g001
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differentially expressed genes, the two knockout samples contained many genes in common
(Fig 3). Heat map representation of the genes that were up- and down-regulated for each of the
knockout conditions versus the ++/+g control highlighted several regions of overly similar dif-
ferential gene expression patterns for the Psip1 and double knockout animals (Fig 4A).
We next examined the top 20 most highly deregulated genes from the above noted pairwise
comparisons (S2–S4 Tables). The expression levels of Psip1 and Hdgfrp2 were deregulated as
expected from these comparisons. For example, Psip1 expression was depressed about 12-fold
from the control in both the Psip1 knockout (not listed in S2 Table because it was not among
the top 20 genes) and double knockout (S3 Table) samples. Similarly, Hdgfrp2 expression was
deregulated about 19-fold between the Psip1 and double knockout samples (S4 Table). As
anticipated from the results in Table 4 and Fig 3, several of the top 20 deregulated genes were
identified in more than one pairwise comparison. For example, the expression levels of Slnf2
and Sp100 were up-regulated similarly from the comparison of Psip1 knockout or double
knockout tissue to the control sample, indicating that the Psip1 deficiency was the likely driving
factor in these expression profiles. The expression levels of several genes, including Ddx3y,
Kdm5d, Uty, Eif2s3y, Prkcq, Alx1, Enpep, Chrdl1, Rspo1, and Tmtc1 were moreover down-regu-
lated in more than one pairwise comparison.
Fig 2. Histological analysis of control and knockout mice. (A) Sagittal section of E14.5 embryos (20X magnification). The gross morphological structures
of brain, lung, liver, kidney, intestines, and other organs appeared similar between −−/gg knockout animals and littermate matched ++/+g controls (n of 4 for
each genotype). Subcutaneous edema and hemorrhage in the knockout animal are marked by triangle and arrow, respectively. (B) Transverse section of
littermate matched control ++/+g (left panel), Psip1 knockout (central panel), and −−/gg double knockout (right panel) E14.5 animals (40X magnification).
Normal, septated ventricles are evident in the central regions of the left and middle panels. Double knockout animals (four out of 4 analyzed) by contrast
presented VSD (highlighted by an asterisk).
doi:10.1371/journal.pone.0137797.g002
Table 4. Numbers of differentially expressed genes between samples.
Comparison Total genes Up-regulated Down-regulated
Psip1 KO to ++/+g 399 186 213
Double KO to ++/+g 406 236 170
Psip1 KO to double KO 37 19 18
KO, knockout.
doi:10.1371/journal.pone.0137797.t004
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Xist, which plays a key role in chromosome X inactivation in mammalian somatic cells [30],
was significantly upregulated by the Psip1 knockout whereas Ddx3y, Kdm5d, Uty, Eif2s3y, each
of which resides on the Y chromosome, were down-regulated significantly (S2 and S4 Tables).
We accordingly wondered if the Psip1 or double knockout influenced the sex of surviving ani-
mals. To address this five different aliquots of DNA prepared fromWT, Psip1 knockout, and
double knockout heart tissue and MEF cells were monitored for the presence of the Y chromo-
some-specific sex-determining region Y (Sry) gene. Because the male-to-female ratios across
all three sets of samples were 3:2 (data not shown), we conclude that, given these somewhat
modest sample sizes, neither the Psip1 nor Psip1/Hdgfrp2 knockout significantly influenced
animal gender. The Psip1 knockout samples subjected to RNA-Seq were derived from one
male and two female embryos, while the double knockout andWT control (++/+g) samples
were each derived from two male and one female animal. We accordingly suspect that this
accounts for the significant levels of deregulated X- and Y-chromosome genes observed in the
Psip1 versus double knockout or WT pairwise combinations (S2–S4 Tables).
Fig 3. Numbers of common genes that are deregulated by Psip1 and Psip1/Hdgfrp2 knockout. (A)
Venn diagram of genes up-regulated by the indicated knockout (KO) showing the overlap between
conditions. The data is from Table 4. (B) Same as in (A), but for down regulated genes.
doi:10.1371/journal.pone.0137797.g003
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Numerous cellular proteins, including Jpo2 [31, 32], Pogz [33], Menin [34], Dbf4/Ask [35],
Mll [36], and Iws1 [37] interact with LEDGF/p75 through the integrase-binding domain while
other factors, including Tox4, Nova1, Mcm7, C3orf59, and Map1a, interact with the PWWP
domain that is in common to both LEDGF/p75 and LEDGF/p52 [38]. The genes that encode
Fig 4. Heat maps of differentially expressed genes by pairwise comparison of knockout versus
control samples. (A) Colors indicate the significance of fold change (log2) values in gene count level. Each
row represents a gene, and each column represents the indicated comparison. Red indicates relative degree
of significance of up-regulation, and green relative significance of down-regulation. Genes that failed to
achieve significant levels of deregulation versus the ++/+g control were scored as zero and appear as black.
(B) Differential expression patterns of Hox genes (upper panel) as well as genes involved in Tfg-β signaling
(central panel) and the Ecm-interaction pathway (lower panel). The data were dissected out from the total
gene expression profiles in panel A. KO, knockout.
doi:10.1371/journal.pone.0137797.g004
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known LEDGF-interacting proteins were queried to ascertain if either the Psip1 knockout or
Psip1/Hdgfrp2 double knockout altered their expression levels in embryonic heart tissue.
Nova1, whose expression was up-regulated approximately threefold by both knockout condi-
tions, was the only gene among this set that scored as significantly deregulated (S5 Table).
Because Nova1 is an RNA splicing factor, the expression levels of 138 additional genes that
were identified from using the gene ontology search term “mRNA splicing, via spliceosome”,
which included the Sfrs1 gene that encodes for the LEDGF/p52-interacting protein ASF/SF2
(see below), were queried. The only other gene with deregulated expression among the
expanded set of RNA splicing factors was Psip1.
RT-PCR was utilized to confirm the expression profiles of a subset of genes that were deter-
mined as differentially regulated by RNA-Seq. For example, significant up-regulation of Slfn
expression was confirmed in both the Psip1 and double knockout samples (about 11-fold in
each), though these values were tampered somewhat from the approximate 48- and 18-fold lev-
els of up-regulation determined by RNA-Seq for the Psip1 knockout and double knockout sam-
ples, respectively (S2 and S3 Tables). Extending this analysis to a set of seven genes that were
deregulated to milder levels (from ~20% to 5-fold; S2A Fig) confirmed the deregulated gene
expression profiles that were detected by RNA-Seq (S2 Fig, compare panels A and B).
Bickmore and colleagues previously noted that Psip1 knockout significantly deregulated the
expression of numerous homeobox (Hox) genes [16, 39], a result that was generally confirmed
here (S2 and S6 Tables; Fig 4B). The expression of the Hoxb13 gene was most significantly up-
regulated, by ~300 to 400-fold, by both Psip1 knockout and double knockout when compared
to matched ++/+g controls. The expression levels of Hoxa1 and Hoxa3, which from the RNA-
Seq analysis were not significantly deregulated by the knockouts, as well asHoxb3 andHoxc9,
which were up-regulated by ~7 to 17-fold (S6 Table), were queried by qRT-PCR. For this anal-
ysis, RNA derived from embryonic head and limb tissue was additionally compared to heart-
derived RNA. While the expression levels ofHoxa1 and Hoxa3 were not significantly altered
by the knockouts, the expression levels ofHoxb3 andHoxc9 were significantly up-regulated, by
~4 to 10-fold, in all tissues examined from knockout animals (S3A Fig). We also confirmed sig-
nificant levels of up-regulation of Hoxb3 and Hoxb13 expression in MEF cells derived from
Psip1 and double knockout animals (S3B Fig).
Gene ontology and pathway analyses of differentially expressed genes
Ontology term analysis of the genes that were differentially expressed between the double
knockout and control samples revealed statistically significant differences in anatomical struc-
ture development, cell differentiation, proteinaceous Ecm, extracelluar region, and cell
Table 5. Significantly deregulated metabolic pathways across samples.
Comparison Up-regulated q-value Down-regulated q-value
Psip1 KO vs. ++/+g n.a. n.a. n.a. n.a.
Double KO vs. ++/+g Ribosome biogenesis in eukaryotes 0.006 Tgf-β pathway 0.04
RNA transport 0.006 Protein digestion and absorption 0.03
Ribosome 0.013 Ecm-receptor interaction 0.03
Focal adhesion 0.01
Lysosome 0.01
Double vs. Psip1 KO n.a. n.a. Tgf-β pathway 0.03
KO, knockout; n.a., not applicable.
doi:10.1371/journal.pone.0137797.t005
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Fig 5. Tgfb1 and Smad expression profiles. (A) RT-PCR analysis of Tgfb1 and Smad1 expression
(average and standard deviation from two independent sets of qRT-PCRmeasurements). Tgfb1 and Smad1
expression levels in the double knockout samples were statistically different from the matched ++/+g controls
in all tissues tested with the exception of Smad1 expression in embryonic limb tissue. n.s., not significant. (B)
Western blot of Smad 2/3 protein levels in the indicated tissues. The migration positions of mass standards in
Embryonic Lethality from Psip1/Hdgfrp2 Double Knockout
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adhesion (S4A Fig). For the comparison between Psip1 knockout and control, proteinaceous
Ecm, extracelluar region, cell adhesion, extracellular space, and nucleic acid binding transcrip-
tion factor activity were significantly enriched among the differentially expressed genes (S4B
Fig).
The GAGE R package was utilized to analyze gene set and KEGG pathways taking into
account all differentially expressed genes and the associated fold change values [20]. Signifi-
cantly regulated KEGG pathways (q-value< 0.1) are reported in Table 5. The comparison of
Psip1 knockout and control ++/+g samples did not yield a significantly regulated pathway. By
contrast, several pathways emerged from comparing the double knockout and control samples:
ribosome, ribosome biogenesis in eukaryotes, and RNA transport were up-regulated, whereas
Tgf-β signaling, protein digestion and absorption, focal adhesion, Ecm-receptor interaction,
and lysosome were down regulated. Comparing the double knockout and Psip1 knockout sam-
ples yielded the sole down regulated pathway of Tgf-β signaling (Table 5).
The Tgf-β signaling pathway regulates different processes related to cardiovascular biology,
including cardiac development and angiogenesis [40, 41]. Knockout of the Tgfb1 gene is
embryonic lethal to mice due to inflammation of the heart and lungs [40, 42] and Tgfb2 knock-
out is embryonic lethal due in part to VSD, myocardial thinning, and a double outlet right ven-
tricle [43]. Pathview visualization revealed significant deregulation of several key genes in the
Tgf-β signaling pathway including Tgfb1, Bmp [44], Activin [45], and Smad [46] (S5 Fig). To
confirm these results, Tgfb1 and Smad1 expression levels were analyzed by qRT-PCR utilizing
RNA extracted from embryonic head, limb, and heart tissues. The expression level of Tgfb1
was significantly down regulated across the tissues derived from double knockout animals,
while Smad1 expression was significantly down regulated in head and in heart tissue (Fig 5A).
Western blot analysis confirmed lower levels of Smad2/3 protein expression in the tissues
derived from the double knockout as compared to Psip1 knockout and control animals (Fig 5B
and 5C).
Heart development depends on the interaction between integrins in cardiomyocytes with
the surrounding Ecm [47] and Tgf-β signaling influences the expression of several integrins
[48–50] and the production of the Ecm [51]. The knockout of β1 integrin moreover resulted in
embryonic lethality with associated cardiac defects [52–54]. We accordingly speculate that
down-regulation of the Ecm receptor interaction pathway could result from the down-regula-
tion of the TGF-β signaling pathway. Focal adhesion kinase (FAK) is a key downstream media-
tor of Ecm-integrin signaling [55] and FAK knockout mice die within hours of birth due to
incomplete formation of the septum between the ventricles and overriding aorta [56]. Down
regulation of the focal adhesion pathway in our embryonic tissue samples is consistent with a
role for TGF-β signaling in the underlying cardiac pathology and prenatal lethality of the dou-
ble knockout Psip1/Hdgfrp2mice.
The transcriptional activities of Hox proteins can be regulated by Smads [57]. Group 13
Hox proteins Hoxa13 and Hoxd13 in particular were reported to interact with Smad5 and
repressed Smad-mediated transcriptional activation [58]. Although this prior study did not
study Hoxb13, it is tempting to speculate that the significant up-regulation of Hoxb13 observed
here could have negatively impacted Smad gene expression and Tgf-β signaling. If true, other
factors, which would be attributable to theHdgfrp2 knockout, must contribute to the VSD, as
the Tfg-β signaling pathway was not deregulated through sole Psip1 knockout (Table 5) yet
kDa are indicated to the left; β-actin was blotted as a protein loading control. (C) Quantification of Smad2/3
proteins normalized for β-actin content for n = 3 independent experiments (average and standard deviation).
*, P < 0.05; **, P < 0.01.
doi:10.1371/journal.pone.0137797.g005
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Hoxb13 expression was similarly up-regulated under both knockout conditions (S6 Table and
S3B Fig).
LEDGF/p52 can interact with the mRNA splicing factor ASF/SF2 (the product of the Sfrs1
gene) and modulate its activity [59, 60], and ASF/SF2 has been identified as a key participant in
regulated postnatal heart remodeling in mice [61]. To ascertain if Psip1 knockout resulted in
differential mRNA splicing in heart tissue, the RNA-Seq data was analyzed using multivariate
analysis of transcript splicing (MATS) [62]. No significant alternative splicing events were
detected by comparing the Psip1 knockout and ++/+g control datasets. Comparing the double
knockout and control samples yielded five alternative splicing events (S7 Table). The expres-
sion level of the Sfrs1 gene, which encodes for ASF/SF2, was not significantly deregulated in
Psip1 knockout (P = 0.64) or Psip1/Hdgfrp2 double knockout (P = 0.69) embryonic ventricular
tissue compared to the matched ++/+g control samples (S5 Table). Although we cannot rule
out a role for mRNA splicing in the VSD, the lack of significant deregulation of RNA splicing
factor gene expression, which was detected for only Nova1 and Psip1 among a set of 139 genes,
leads us to believe that differential splicing was not a driving factor in the underlying pathology
of VSD.
Conclusions
Our genetically null Psip1 knockout mice phenocopied the perinatal lethality previously
reported using gene trap vector insertion [16]. While knockout of the related HRP2 protein
product did not detectably influence mouse development, Psip1/Hdgfrp2 double deficiency
resulted in embryonic lethality at approximate E13.5 with associated VSD. RNA-Seq analysis
revealed significant deregulation of the Tgf-β signaling pathway as well as deregulation of
downstream Ecm-interaction and focal adhesion pathways in the tissue of double knockout
animals. The expression levels of genes that encode for key LEDGF/p75 interacting proteins,
such as Menin and Mll, were not altered by the knockouts described here. Though the expres-
sion level of the Nova1 gene, which encodes for an RNA splicing factor that interacts with
LEDGF/p75, was up-regulated, the expression levels of genes that encode for other RNA splic-
ing factors, including the key LEDGF/p52 interactor ASF/SF2, were not altered significantly.
We conclude that the deregulation the Tgf-β signaling pathway was a likely contributing factor
to abnormal cardiac morphogenesis and prenatal mortality of the Psip1/Hdgfrp2 double-defi-
cient mice.
Supporting Information
S1 Fig. Genotypic and phenotypic characterization of animals generated during the double
knockout mating scheme. (A) Genomic DNA from tails of mouse embryos were subjected to
PCR using the indicated primer pairs. Primers AE2331 and AE2802 detect a 803 bp product
from wild-type Psip1 DNA whereas exon 3 deletion yields a 324 bp fragment [15]. The 535 bp
Hdgfrp2 product (primers AE2511, AE2512) is disrupted by gene trap insertion; primers
AE3747 and AE3748, specific for the pGT2lfx vector, detect a 433 bp product in all cell types
[10]. The migration positions of expected DNA products in bp and of mass standards in kb are
shown to the left and right sides of the gels, respectively. DNA was detected by ethidium bro-
mide staining. (B) Phenotypic characterization of Hdgfrp2mRNA expression levels using the
indicated primer pairs. P values from the indicated comparisons of expression levels are
shown. (C) Psip1mRNA expression levels. The data in panels B and C are averages and stan-
dard deviation of three independent experiments, with qRT-PCR samples conducted in dupli-
cate for each experiment.
(PDF)
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S2 Fig. RT-PCR analysis of a subset of genes that were detected by RNA-Seq as differen-
tially regulated by Psip1 and/or Psip1/Hdgfrp2 knockout. (A) RNA-Seq data expressed as
log2 fold changes in mRNA expression levels with associated P values for the seven indicated
genes. (B) Results from qRT-PCR analysis (average and standard deviation from three inde-
pendent sets of qRT-PCR measurements). The levels of gene expression in the double knock-
out samples in panel B were statistically different (P< 0.05) from the matched ++/+g controls
for all seven genes whereas the levels of expression of only two genes in the Psip1 knockout
samples, Integrin α1 and Caveolin 2, achieved significance versus the controls. n.s., not signifi-
cant (control versus Psip1 knockout comparison).
(PDF)
S3 Fig. RT-PCR analysis ofHox gene expression. (A) Results from qRT-PCR analysis of the
indicated Hox genes in different embryonic tissue (average and standard deviation from two
independent sets of qRT-PCR measurements). Hoxb3 andHoxc9 gene expression levels in the
double knockout and Psip1 knockout samples were statistically different from the matched +
+/+g controls across tissues, while Hoxa1 and Hoxa3 gene expression levels were not. (B) Lev-
els ofHoxb3 and Hoxb13 expression in Psip1 and Psip1/Hdgfrp2 knockout MEFs. The expres-
sion of both Hoxb3 and Hoxb13 was significantly up-regulated (average and standard
deviation from two independent sets of qRT-PCR measures). , P< 0.01.
(PDF)
S4 Fig. Enriched gene ontology terms between expression patterns in control and knockout
ventricular tissue. (A) Comparison of double knockout (−−/gg) versus control samples. (B)
Psip1 knockout versus control.
(PDF)
S5 Fig. KEGG analysis of differential gene expression in the Tgf-β signaling pathway. The
data is from the comparison of double knockout and ++/+g control samples. Symbol codes:
+p, phosphorylation;-p, dephosphorylation; +u, ubiquitination;! o!, activation; –| o!,
repression. Dashed lines indicate indirect effects. The heat map key indicates relative degrees of
significance in levels of transcriptional down-regulation (green) and up-regulation (red).
(PDF)
S1 Table. Sequences of PCR primers.
(PDF)
S2 Table. Top 20 differentially expressed genes comparing Psip1 knockout to control
++/+g tissue.
(PDF)
S3 Table. Top 20 differentially expressed genes comparing Psip1/Hdgfrp2 knockout to con-
trol ++/+g tissue.
(PDF)
S4 Table. Top 20 differentially expressed genes comparing Psip1 knockout to Psip1/
Hdgfrp2 knockout tissue.
(PDF)
S5 Table. Gene expression profiles of LEDGF interacting proteins vs. ++/+g control.
(PDF)
S6 Table. Differential expression ofHox genes in pairwise tissue comparisons.
(PDF)
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S7 Table. Alternatively spliced genes in double knockout versus control ++/+g samples.
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